Sarcoma & GIST
From the Journals
After implementation of the default order specifying no daily imaging during palliative radiation therapy, patients were 63% less likely to...
Nearly a quarter of the patients screened as part of the National Cancer Institute–Children’s Oncology Group Pediatric MATCH trial have been...
Entrectinib produced responses in patients who had fusions or mutations in target genes.
Missing efficacy data from the pivotal ENLIVEN trial and adverse liver events were points of contention.
ATLANTA – A teenage girl with advanced osteosarcoma has had a durable complete remission after receiving CAR T cells targeted to HER2.
ATLANTA – Although HER2 expression in osteosarcoma and rhabomyosarcoma is too low for HER2-targeted therapies such...